Cough Syrup Warning Will Not Affect Existing Stock: HC Relief to Glenmark, Zuventus Farhat Nasim26 April 2025 7:09 PM ISTNew Delhi: In a major relief to pharma companies Glenmark Pharmaceuticals Ltd. and Zuventus Healthcare Ltd., the Delhi High Court has ruled that the...
US Market Pressure Weighs on Glenmark's Q3 Earnings, Profit Below Estimates Farhat Nasim15 Feb 2025 3:35 PM ISTGlenmark reported a consolidated net profit of 3.48 billion rupees (USD 40.15 million) for the quarter ended December 31.
Glenmark's Win: NPPA revises price of Telmisartan, Cilnidipine FDC after data review Farhat Nasim3 Dec 2024 2:57 PM ISTNew Delhi: Drug maker, Glenmark Pharmaceuticals' appeal against the earlier price fixation for its cardiovascular drug combination, Cilnidipine 20 mg...
DoP rejects Glenmark's appeal on price cap of Clotrimazole Cream Farhat Nasim3 Nov 2024 12:45 PM ISTNew Delhi: The Department of Pharmaceuticals has upheld the National Pharmaceutical Pricing Authority's (NPPA) decision on the price cap for...
Manufacturing Defects: Glenmark Subsidiary Recalls Products in US Meghna A Singhania14 Oct 2024 1:14 PM ISTNew York: Glenmark Pharmaceuticals is recalling two products in the U.S. due to manufacturing problems, as reported by the U.S. Food and Drug...
30 Formulations declared Not of Standard Quality as per data provided by states: CDSCO Drug Alert Dr. Divya Colin24 July 2024 6:00 PM ISTNew Delhi: In line with the 'Not of Standard Quality' data provided by states, the apex drug regulatory body, the Central Drug Standard Control...
CDSCO declares 5 formulations as spurious: Details Dr. Divya Colin17 Jun 2024 6:00 PM ISTNew Delhi: In the latest spurious drug alert, the apex drug regulatory body, the Central Drug Standard Control Organization (CDSCO), has declared 5...
Include nebulization methodology, nebulizer types: CDSCO Panel Tells Glenmark pharmaceuticals on Pulmonary FDC Dr. Divya Colin14 Jun 2024 6:00 PM ISTNew Delhi: Citing to include nebulization methodology, type of nebulizer, and interface, the Subject Expert Committee (SEC) functional under the...
Glenmark Pharmaceuticals Gets CDSCO Panel Nod to Study Lobeglitazone Sulfate, Glimepiride FDC Table Dr. Divya Colin16 April 2024 6:00 PM ISTNew Delhi: Glenmark Pharmaceuticals, a major pharmaceutical company, has received approval from the Subject Expert Committee (SEC) operating under the...
Justify dose of Bilastine: CDSCO Panel tells Glenmark on FDC of Bilastine, Dextromethorphan ,Phenylephrine Syrup Dr. Divya Colin17 May 2022 7:10 PM ISTNew Delhi: Rejecting the pharmaceuticals major Glenmark proposal for bioequivalence (BE) study waiver of fixed dose combination drug Bilastine 3.3mg...
Glenmark gets CDSCO panel nod to manufacture and market COPD drug Dr. Divya Colin9 May 2022 6:52 PM ISTNew Delhi: Based on the justification provided by the pharmaceutical major Glenmark pharmaceuticals, the Subject Expert Committee (SEC) of the Central...
Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets MD Bureau21 March 2022 3:48 PM ISTAccording to IQVIA sales data for the 12 month period ending January 2022, the Vimpat Tablets, 50 mg, 100 mg, 150 mg and 200 mg market3 achieved...
